You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TMC310911

Showing 1 - 4 of 4
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Beijing (ASC09F)

Completed
  • Healthy
  • Beijing, Beijing, China
    Beijing Youan Hospital, Capital Medical University
Jan 7, 2021

HIV Trial in Utrecht (TMC589337 40 mg, TMC589337 100 mg, TMC589337 200 mg)

Withdrawn
  • HIV Infections
  • TMC589337 40 mg
  • +16 more
  • Utrecht, Netherlands
    (unnamed)
Oct 27, 2016

Human Immunodeficiency Virus Type 1 Trial in Berlin, Frankfurt, Hamburg (TMC310911 75 mg twice daily, TMC310911 150 mg twice

Completed
Has Results
  • Human Immunodeficiency Virus Type 1
  • TMC310911 75 mg twice daily
  • +5 more
  • Berlin, Germany
  • +2 more
Jun 3, 2013

HIV-1 Trial (TMC558445; TMC310911; Darunavir; Placebo)

Completed
  • HIV-1
  • TMC558445; TMC310911; Darunavir; Placebo
  • (no location specified)
Apr 26, 2010